Sigma Healthcare Ltd (ASX: SIG) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Sigma Healthcare Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $32.90 billion
P/E Ratio 53.53
Dividend Yield 0.48%
Shares Outstanding 11.54 billion
Earnings per share -0.009
Dividend per share 0.04
Year To Date Return -5.44%
Earnings Yield 1.87%
Franking 100%
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • Sigma Healthcare Ltd (ASX: SIG)
    Latest News

    Woman in celebratory fist move looking at phone.
    Investing Strategies

    5 ASX shares I'd buy and hold for the next decade

    These companies have scalable platforms and strong market positions.

    Read more »

    A woman wearing dark clothing and sporting a few tattoos and piercings holds a phone and a takeaway coffee cup as she strolls under the Sydney Harbour Bridge which looms in the background.
    Share Market News

    5 Australian stocks to buy and hold for the next 5 years

    Healthcare, financial tech, consumer brands, and resources. Five Australian stocks for long-term investors.

    Read more »

    A male ASX 200 broker wearing a blue shirt and black tie holds one hand to his chin with the other arm crossed across his body as he watches stock prices on a digital screen while deep in thought
    Share Market News

    5 things to watch on the ASX 200 on Wednesday

    It looks set to be a tough session for Aussie investors on hump day.

    Read more »

    Red arrow going down and symbolising a falling share price.
    52-Week Lows

    3 ASX 200 shares at 52-week lows: Buy, hold, or sell?

    Is there value here?

    Read more »

    man looks at phone while disappointed
    Broker Notes

    Buy, hold, sell: HMC Capital, Ramsay Health Care, and Sigma shares

    Morgans has given its verdict on these shares this month.

    Read more »

    A graphic of a pink rocket taking off above an increasing chart.
    Opinions

    2 great ASX 200 blue-chip shares I'd buy right now

    I think these stocks are undervalued after the results.

    Read more »

    A senior pharmacist talks to a customer at the counter in a shop.
    Broker Notes

    Is it too late to buy the shares of Chemist Warehouse owner Sigma?

    Let's see what Bell Potter is saying about this giant.

    Read more »

    Overjoyed man celebrating success with yes gesture after getting some good news on mobile.
    Share Gainers

    Why Accent Group, DroneShield, IDP Education, and Sigma shares are jumping today

    These shares are catching the eye on Thursday. What's going on?

    Read more »

    Female pharmacist smiles with a digital tablet.
    Earnings Results

    Sigma shares jump 7% on results and Chemist Warehouse expansion

    Business is booming for Chemist Warehouse.

    Read more »

    A senior pharmacist talks to a customer at the counter in a shop.
    Earnings Results

    Sigma Healthcare shares: 1H26 profit and sales leap

    Sigma Healthcare reported double-digit sales and profit growth for 1H26, with Chemist Warehouse network expansion driving the result.

    Read more »

    A woman looks nonplussed as she holds up a handful of Australian $50 notes.
    Blue Chip Shares

    5 ASX 200 blue chip stocks I would buy with $50,000

    Market cycles come and go. I want businesses I can hold through all of them.

    Read more »

    Worried woman calculating domestic bills.
    Bank Shares

    Why I'd forget NAB shares and buy these top Aussie stocks

    At a record high, I see more upside in these ASX blue chips than the big four bank.

    Read more »

    Dividend Payment History Data provided by Morningstar.

    Data provided by Morningstar.
    Ex-Date Amount Franking Type Payable
    04 Mar 2026 $0.0200 100.00% Final 20 Mar 2026
    02 Sep 2025 $0.0130 100.00% Interim 18 Sep 2025
    01 Oct 2024 $0.0050 0.00% Interim 17 Oct 2024
    28 Mar 2024 $0.0050 50.00% Final 17 Apr 2024
    25 Sep 2023 $0.0050 100.00% Interim 11 Oct 2023
    30 Mar 2023 $0.0050 100.00% Final 18 Apr 2023
    29 Sep 2022 $0.0050 100.00% Interim 12 Oct 2022
    04 Apr 2022 $0.0100 100.00% Final 22 Apr 2022
    24 Sep 2021 $0.0100 100.00% Interim 08 Oct 2021
    06 Apr 2021 $0.0100 100.00% Final 21 Apr 2021
    19 Sep 2019 $0.0100 100.00% Interim 04 Oct 2019
    03 Apr 2019 $0.0200 100.00% Final 29 Apr 2019
    12 Oct 2018 $0.0150 100.00% Interim 29 Oct 2018
    05 Apr 2018 $0.0250 100.00% Final 20 Apr 2018
    19 Sep 2017 $0.0250 100.00% Interim 05 Oct 2017
    06 Apr 2017 $0.0300 100.00% Final 21 Apr 2017
    20 Sep 2016 $0.0250 100.00% Interim 03 Oct 2016
    06 Apr 2016 $0.0300 100.00% Final 21 Apr 2016
    03 Apr 2014 $0.0200 100.00% Final 30 Apr 2014
    21 Sep 2012 $0.0200 100.00% Interim 26 Oct 2012
    05 Apr 2011 $0.1500 100.00% Special Cash 11 May 2011
    16 Oct 2009 $0.0300 100.00% Interim 13 Nov 2009
    31 Mar 2009 $0.0400 100.00% Final 07 May 2009
    30 Sep 2008 $0.0300 100.00% Interim 29 Oct 2008
    29 Aug 2005 $0.0200 100.00% Interim 15 Sep 2005
    02 Mar 2004 $0.2000 100.00% Final 23 Mar 2004

    SIG ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Sigma Healthcare Ltd

    Sigma Healthcare Ltd. engages in the manufacture and distribution of pharmaceutical products through pharmacy, grocery channels, and private label. The firm operates through the Amcal, Guardian, PharmaSave, Chemist King, and Discount Drug Stores retail brands. It also involves in the provision of services to retail pharmacists in Australia. The company was founded on July 2, 1999 and is headquartered in Rowville, Australia.

    SIG Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    06 Mar 2026 $2.85 $0.05 1.79% 22,326,103 $2.79 $2.90 $2.78
    05 Mar 2026 $2.80 $0.04 1.45% 21,137,349 $2.75 $2.82 $2.73
    04 Mar 2026 $2.76 $0.03 1.10% 19,358,250 $2.71 $2.78 $2.71
    03 Mar 2026 $2.73 $-0.02 -0.73% 18,087,567 $2.75 $2.78 $2.70
    02 Mar 2026 $2.75 $-0.09 -3.17% 15,388,595 $2.80 $2.84 $2.72
    27 Feb 2026 $2.84 $-0.10 -3.40% 42,750,596 $2.94 $2.95 $2.81
    26 Feb 2026 $2.94 $-0.05 -1.67% 47,780,844 $3.15 $3.20 $2.93
    25 Feb 2026 $2.99 $-0.01 -0.33% 14,882,933 $2.99 $3.03 $2.98
    24 Feb 2026 $3.00 $0.03 1.01% 12,886,496 $2.98 $3.03 $2.96
    23 Feb 2026 $2.97 $0.03 1.02% 11,080,410 $2.95 $2.98 $2.93
    20 Feb 2026 $2.94 $-0.04 -1.34% 10,640,247 $2.98 $3.04 $2.94
    19 Feb 2026 $2.98 $-0.01 -0.33% 8,813,661 $2.99 $3.00 $2.95
    18 Feb 2026 $2.99 $-0.03 -0.99% 7,767,770 $3.02 $3.06 $2.98
    17 Feb 2026 $3.02 $0.01 0.33% 8,938,542 $3.03 $3.04 $2.99
    16 Feb 2026 $3.01 $-0.02 -0.66% 10,868,700 $3.03 $3.05 $3.00
    13 Feb 2026 $3.03 $-0.02 -0.66% 15,581,661 $3.06 $3.07 $3.01
    12 Feb 2026 $3.05 $-0.05 -1.61% 20,094,391 $3.09 $3.10 $3.03
    11 Feb 2026 $3.10 $0.01 0.32% 14,691,987 $3.11 $3.12 $3.05
    10 Feb 2026 $3.09 $-0.03 -0.96% 11,101,677 $3.10 $3.13 $3.08
    09 Feb 2026 $3.12 $-0.01 -0.32% 31,205,588 $3.13 $3.15 $3.09
    06 Feb 2026 $3.13 $-0.03 -0.95% 45,118,852 $3.15 $3.16 $3.08
    05 Feb 2026 $3.16 $0.00 0.00% 20,117,221 $3.17 $3.19 $3.13
    04 Feb 2026 $3.16 $0.02 0.64% 27,022,299 $3.12 $3.16 $3.11

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    09 Jan 2026 Vikesh Ramsunder Issued 813,449 $2,350,867
    Issue of securities. 1824172 Rights
    09 Jan 2026 Danielle Di Pilla Issued 141,591 $409,197
    Issue of securities. 141,591 2025 LTI Rights
    09 Jan 2026 Mario Verrocchi Issued 314,021 $907,520
    Issue of securities. 314,021 2025 LTI Rights
    10 Nov 2025 Annette Carey Buy 10,000 $31,237
    On-market trade.
    28 Aug 2025 Jack Gance Sell 155,103,420 $480,820,602
    Off-market trade.
    29 May 2025 Danielle Di Pilla Sell 7,342,150 $23,312,794
    On-market trade.
    28 May 2025 Danielle Di Pilla Sell 7,500,000 $24,000,000
    On-market trade.
    27 May 2025 Danielle Di Pilla Sell 14,764,652 $46,609,053
    On-market trade.
    26 May 2025 Danielle Di Pilla Sell 235,348 $741,346
    On-market trade.
    09 May 2025 Damien Gance Sell 126,500,000 $382,030,000
    Off-market trade.
    14 Apr 2025 Damien Gance Sell 100,000,000 $297,000,000
    Off-market trade.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Dr Christopher Graham Roberts Non-Executive Director Oct 2023
    Dr Roberts has more than 40 years of experience in the medical device industry, including as the former Chief Executive Officer of Cochlear Limited from 2004 to 2015, Executive Vice President of ResMed Inc (NYSE:RMD) from 1992 to 2003 and as a director of ResMed Inc until November 2017. He is currently a non-executive director of HMC Capital Ltd (ASX:HMC). HMC Capital managed HealthcCo Healthcare and Wellness REIT (ASX:HCW), HMC Capital Partners Fund 1, Clarity Pharmaceuticals Limited (ASX:CU6), Nutromics Pty Ltd, Atmo Biosciences Limited and the Cochlear Foundation Board. He is also a Governor of the Centenary Institute Cancer Medicine and Cell Biology.
    Mr Neville Mitchell Non-Executive Director Feb 2023
    Mr Mitchell has international healthcare and finance experience. He was Chief Financial Officer and Company Secretary at ASX-listed Cochlear Limited, a world leading medical device developer, manufacturer and seller of hearing devices. Mr Mitchell is currently the Chairman of ASX and NZX-listed Fisher&Paykel Healthcare Corporation (non-executive director from November 2018) and a non-executive director of Sonic Healthcare Limited from September 2017. He is Chair of the Sonic Audit Committee. He was formerly a non-executive director of ASX-listed Sirtex Healthcare, Osprey Medical Inc and Q'Biotics Group Limited. He has also performed roles with several industry and Government committees.
    Mr Michael Sammells Non-Executive DirectorNon-Executive Chairman Feb 2020
    Mr Sammells is also currently a non-executive director at AMP Limited and a director at GMBHA. He has 35 years of broad experience in finance, corporate services and has held operational roles with expertise in finance, accounting, treasury, investor relations, capital development, mergers and acquisitions and IPOs. Further, Mr Sammells is a former Chief Financial Officer of Healthscope Limited and Medibank Private.
    Mr Vikesh Ramsunder Chief Executive OfficerManaging Director Feb 2022
    Mr Ramsunder has experience in pharmacy retailing, wholesaling and logistics. He spent 28 years with the Clicks Group in South Africa. This included 18 years as part of the executive team. Before becoming Clicks Group Chief Executive Officer in January 2019, Mr Ramsunder held several roles within Clicks, including Chief Operating Officer from 2015 and Managing Director of the pharmaceutical wholesale business, United Pharmaceutical Distributors from 2010.
    Ms Annette May Carey Non-Executive Director Apr 2023
    Ms Carey is a current non-executive director of National Intermodal Corporation and a non-executive director of the Kinetic bus group. Prior to joining Sigma, Ms Carey has held director roles within the Linfox group of companies and has been Chair or Deputy Chair of Australia Post joint ventures in the UK and China. She has previously held various senior roles within the Linfox Logistics group, progressing from General Counsel and Company Secretary to Chief Executive Officer. Ms Carey also held the position of Executive General Manager International with Australia Post. Ms Carey is a member of Chief Executive Women.
    Mr Jack Gance Non-Executive Director Feb 2025
    Mr D Gance is a qualified pharmacist who joined MyChemist in 1998 and is currently the Chief Commercial Officer of Chemist Warehouse. Mr D Gance was the first Chemist Warehouse Franchisee opening the first Chemist Warehouse pharmacy in June 2000.
    Ms Danielle Di Pilla Executive Director Feb 2025
    Ms Di Pilla is a qualified pharmacist who is currently the Chief People Officer at Chemist Warehouse. Ms Di Pilla established DPP Pharmaceuticals Pty Ltd (DPP) in 2000 and is the founder of brands such as Goat Soap, which has had international success. Ms Di Pilla has been the managing director of DPP since it was incorporated. DPP is a wholly owned subsidiary of Chemist Warehouse. Ms Di Pilla also sits on the Board of Gotcha4Life.
    Mr Mario Verrocchi Executive Director Feb 2025
    Mr Verrocchi joined Jack and Sam Gance's pharmacy group in 1982. Mr Verrocchi established MyChemist with Jack Gance and Sam Gance in 1997 and subsequently created the Chemist Warehouse chain with Messrs Gance in 2000. He is currently Chief Executive Officer of Chemist Warehouse.
    Mr Damien Gance Executive Director Feb 2025
    Mr J Gance as a pharmacist in 1967 and opened his first pharmacy store in Reservoir, Victoria, with Sam in 1972. In 1997, Mr J Gance, Sam Gance and Mario Verrocchi, established MyChemist and opened the first MyChemist store. In 2000, Mr J Gance, along with Mr Sam Gance and Mr Verrocchi, established the Chemist Warehouse chain and opened the first Chemist Warehouse store. Mr J Gance also created the brands Le Specs, Le Tan and Colours of Australis.
    Ms Kara McGowan General CounselCompany Secretary Oct 2021
    -
    Kara McGowan General CounselCompany Secretary
    -
    Mr M Conway Chief Financial Officer
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    HSBC Custody Nominees (Australia) Limited 871,241,938 14.61%
    Citicorp Nominees Pty Limited 445,477,631 7.47%
    J P Morgan Nominees Australia Pty Limited 359,556,170 6.03%
    Dgsr Family Foundation Pty Ltd 353,829,615 5.93%
    Av Family Foundation Pty Ltd 313,784,873 5.26%
    Mjv Family Foundation Pty Ltd 313,784,873 5.26%
    Mr Sunil Narula 165,893,114 2.78%
    Bond Street Custodians Limited 150,545,209 2.52%
    Mat Family Foundation Pty Ltd 148,144,781 2.48%
    HMC Capital Partners Holdings Pty Ltd 103,399,008 1.73%
    Ms Nancy Fei Fei Jian 86,118,340 1.44%
    HSBC Custody Nominees (Australia) Limited Gsco Eca 75,333,468 1.26%
    Mr Azman Rashid Haroon 64,502,845 1.08%
    Ms Danielle Di Pilla 61,243,218 1.03%
    Mr Claudio Avendano 55,986,398 0.94%
    Citicorp Nominees Pty Limited i 51,603,737 0.87%
    Bond Street Custodians Limited i 48,455,727 0.81%
    Di Pilla Investments Pty Ltd 44,228,054 0.74%
    Mr William Ho 41,669,145 0.70%
    Bond Street Custodians Limited ii 41,505,949 0.73%
    Mr Anthony Paul Bassaly 39,768,975 0.67%

    Profile

    since

    Note